http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2569276-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_853249c166c80fa802fecbf69fcac430
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
filingDate 1984-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534351964134a9ccc56d4b5cf11acad4
publicationDate 1986-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2569276-A1
titleOfInvention PROCESS FOR DETERMINING FIBRINOGENIC DEGRADATION PRODUCTS
abstract THE PRESENT INVENTION CONCERNS A NEW METHOD FOR ASSESSING FIBRINOGEN AND FIBRIN DEGRADATION PRODUCTS (PDF), ESPECIALLY ON PLASMA. THIS PROCESS, WHICH APPLIES AN ANTI-BODY ANTI-PTO IN AN ANTI-BODY-ANTIBODY REACTION, IS CHARACTERIZED IN THAT AN ANTI-PTO MONOCLONAL ANTIBODY IS PLACED IN CONTACT WITH AN AQUEOUS LIQUID MEDIUM LIKELY TO CONTAIN AT LEAST ONE PTO, LEDIT MONOCLONAL ANTI-PDF ANTIBODY WHICH IS PURIFIED, DOES NOT REACT WITH FIBRINOGEN AND IS FIXED ON AN INERT SUPPORT, ALLOWING TO DETECT THE PRESENCE OF PDF BY MACROSCOPIC AGGLUTINATION, THE ABSENCE OF AGGLUTINATION INDICTING THE ABSENCE OF PDF. IT IS USEFUL IN THE REALIZATION OF READY-TO-USE ASSEMBLIES OR DOSAGE KITS.
priorityDate 1984-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0124320-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0122478-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463117
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R8X6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7M323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19123
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29485
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83169
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81286
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18783
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID733660
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00747
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403602
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06867
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID421580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80010
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12545
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33574
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5555

Total number of triples: 52.